NCT06884085View on ClinicalTrials.gov

A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Primary Hypertension
Interventions
DRUG

Co-administration of AD-227A and AD-227B

Co-administration of AD-227A 1Tab. and AD-227B 1Tab., Per Oral

DRUG

Administration of AD-227

Administration of AD-227 1Tab., Per Oral

Trial Locations (1)

Unknown

RECRUITING

Central Hospital, Seoul

All Listed Sponsors
lead

Addpharma Inc.

INDUSTRY